INHIBIKASE THERAPEUTICS, INC.
INHIBIKASE THERAPEUTICS, INC. is a registered legal entity registered in United States under 4832244, and its current status with Delaware Division of Corporations is active. The company was incorporated on 6 March 2010 and lists its registered address as United States. 3 shareholders are on record for INHIBIKASE THERAPEUTICS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Delaware Division of Corporations and was last updated on 4 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
3
Three shareholders are currently on record for INHIBIKASE THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Adar1 Capital Management, LLC , holding 7.7% — the largest recorded stake — followed by Adar1 Capital Management, LLC at 7.7%; the remaining 1 shareholder shown holds smaller stakes.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Adar1 Capital Management, LLC | 7.7% | Delaware Division of Corporations | |
| Adar1 Capital Management, LLC | 7.7% | Delaware Division of Corporations | |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 0.2% | Delaware Division of Corporations |
Officers
5
The Controller of INHIBIKASE THERAPEUTICS, INC. currently on record is Dan Williams; five officers are currently on record for INHIBIKASE THERAPEUTICS, INC., filed with Delaware Division of Corporations.
The register reports 13 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at INHIBIKASE THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
INHIBIKASE THERAPEUTICS, INC. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 2 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
INHIBIKASE THERAPEUTICS, INC.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns INHIBIKASE THERAPEUTICS, INC.?
Three shareholders are currently on record for INHIBIKASE THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Adar1 Capital Management, LLC , holding 7.7% — the largest recorded stake — followed by Adar1 Capital Management, LLC at 7.7%; the remaining 1 shareholder shown holds smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is INHIBIKASE THERAPEUTICS, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for INHIBIKASE THERAPEUTICS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does INHIBIKASE THERAPEUTICS, INC. have on record?
3 shareholders are shown on record for INHIBIKASE THERAPEUTICS, INC..
What is INHIBIKASE THERAPEUTICS, INC.'s company registration number?
INHIBIKASE THERAPEUTICS, INC.'s registration number is 4832244, filed with Delaware Division of Corporations in United States. Its current status on the register is active.
Is INHIBIKASE THERAPEUTICS, INC. still an active company?
INHIBIKASE THERAPEUTICS, INC.'s status on Delaware Division of Corporations is listed as active.
When was INHIBIKASE THERAPEUTICS, INC. incorporated?
INHIBIKASE THERAPEUTICS, INC. was incorporated on 6 March 2010, according to Delaware Division of Corporations.
What is INHIBIKASE THERAPEUTICS, INC.'s registered address?
The registered address on file for INHIBIKASE THERAPEUTICS, INC. is United States.
Who are the officers/directors of INHIBIKASE THERAPEUTICS, INC.?
The Controller of INHIBIKASE THERAPEUTICS, INC. currently on record is Dan Williams; five officers are currently on record for INHIBIKASE THERAPEUTICS, INC., filed with Delaware Division of Corporations. Management authority at INHIBIKASE THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does INHIBIKASE THERAPEUTICS, INC. have a parent company or subsidiaries?
INHIBIKASE THERAPEUTICS, INC. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 1 jurisdiction. Those 2 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to INHIBIKASE THERAPEUTICS, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from Delaware Division of Corporations. Zavia's monitoring API can track changes to INHIBIKASE THERAPEUTICS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access INHIBIKASE THERAPEUTICS, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like INHIBIKASE THERAPEUTICS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Delaware Division of Corporations and was last synced on 4 October 2026.